Brief: Cartesian Therapeutics Regains Compliance With $1 Per Share Minimum Bid Price Requirement For Continued Inclusion On Nasdaq
22/04/2024 11:29
April 22 (Reuters) - Cartesian Therapeutics Inc
RNAC.O :
* CARTESIAN THERAPEUTICS INC - REGAINED COMPLIANCE WITH
$1.00 PER
SHARE MINIMUM BID PRICE REQUIREMENT FOR CONTINUED INCLUSION ON
NASDAQ
Source text for Eikon: ID:n0001453687-24-000072
Further company coverage: RNAC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cartesian Therapeutics
See all newsBrief: Cartesian Therapeutics Announces Additional Retreatment Data For Descartes-08 Highlighting Deep And Durable Responses In Patients With Myasthenia Gravis
Cartesian Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cartesian Therapeutics Q2 net income steady
Brief: Cartesian Therapeutics Inc Q2 Net Income USD 15.769 Million
Cartesian Therapeutics Inc expected to post a loss of 87 cents a share - Earnings Preview